Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100609753 | 10060975 | 3 | F | 20140202 | 20150320 | 20140405 | 20150331 | EXP | SE-ROCHE-1378348 | ROCHE | 77.00 | YR | F | Y | 0.00000 | 20150331 | N | MD | SE | SE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100609753 | 10060975 | 1 | PS | LUCENTIS | RANIBIZUMAB | 1 | INTRAOCULAR | STRENGTH: 10MG/ML | D | 125156 | 1 | DF | |||||||
| 100609753 | 10060975 | 2 | C | EYLEA | AFLIBERCEPT | 1 | OTHER | 40 MG/ML | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100609753 | 10060975 | 1 | Age-related macular degeneration |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100609753 | 10060975 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100609753 | 10060975 | Cerebrovascular accident |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100609753 | 10060975 | 1 | 20120725 | 0 | ||
| 100609753 | 10060975 | 2 | 20140131 | 0 |